Hikma Pharmaceuticals Public annual net profit margin
2020
2021
2022
2023
2024
2025
Hikma Pharmaceuticals Public Net Profit Margin Growth & History (HIK)
Hikma Pharmaceuticals Public's net profit margin was 12.15% for fiscal 2025.
View full Hikma Pharmaceuticals Public company overviewHikma Pharmaceuticals Public annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 12.15% | +0.58 pp |
| 2024 | 2024-12-31 | 11.58% | +4.90 pp |
| 2023 | 2023-12-31 | 6.68% | −0.91 pp |
| 2022 | 2022-12-31 | 7.59% | −8.86 pp |
| 2021 | 2021-12-31 | 16.45% | −1.92 pp |
| 2020 | 2020-12-31 | 18.37% | — |
Hikma Pharmaceuticals Public net profit margin trends
Over the last five fiscal years, Hikma Pharmaceuticals Public's net profit margin decreased from 18.37% to 12.15%, a change of −6.22 percentage points.
About the metric
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
Calculation and source
How net profit margin is calculated
TickerStat calculates net profit margin as reported net income divided by reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Hikma Pharmaceuticals Public source filings ↗Community posts
Hikma’s epinephrine nasal spray advances into regulatory review
Hikma ($HIK) said regulators in the United States, Europe and the UK have accepted submissions for its investigational epinephrine nasal spray for review. The company has also filed in Canada and intends to expand submissions to additional ...